Mark L. Dyken

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Thrombosis, Ischemic Stroke, Cardiovascular Disease +9

Cardiogenic brain embolism. The second report of the Cerebral Embolism Task Force.

Richard Asinger, Mark L. Dyken, Marc Fisher et al. · PubMed · 1989 · 548 citations

Left Ventricular Thrombi, Cerebrovascular Disease, Neurovascular Disease +23

Aspirin as a Therapeutic Agent in Cardiovascular Disease

Charles H. Hennekens, Mark L. Dyken, Valentı́n Fuster · Circulation · 1997 · 436 citations

Thrombosis, Cardiovascular Disease, Medicine +7

Risk Factors

Ralph L. Sacco, Emelia J. Benjamin, Joseph P. Broderick et al. · Stroke · 1997 · 412 citations

The performance of endarterectomy for disease of the extracranial arteries of the head.

Mark L. Dyken, R Pokras · Stroke · 1984 · 209 citations · Full text

Extracranial Arteries, Armed Forces Hospitals, Carotid Artery Surgery +15